Tevogen (TVGN) Notes Payables (2023 - 2026)
Tevogen Bio Holdings' (TVGN) quarterly Notes Payables came in at $1.7 million in Q1 2026, little changed YoY from $1.7 million in Q1 2025, and little changed on a QoQ basis from $1.7 million in Q3 2025.
Tevogen (TVGN) Notes Payables (2023 - 2026) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 4 years of Notes Payables data on file, last reported at $1.7 million in Q1 2026.
- Quarterly Notes Payables changed 0.0% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (changed 0.0% YoY) and the FY2023 annual result came in at $80.7 million, changed N/A from the prior year.
- Notes Payables held at $1.7 million in Q1 2026, from $1.7 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $80.7 million in Q4 2023 to a low of $625694.0 in Q2 2023.
- A 4-year average of $9.4 million and a median of $1.7 million in 2024 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables surged 163.87% — and 2025, when it changed 0.0%.
- Tracing TVGN's Notes Payables over 4 years: stood at $80.7 million in 2023, then tumbled by 97.95% to $1.7 million in 2024, then changed by 0.0% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
- The last three Notes Payables figures came in at $1.7 million (Q1 2026), $1.7 million (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - |
| 10 | Tevogen | 26.21 Mn | 26.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.65 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 1.65 Mn |
| Mar 31, 2025 | 1.65 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.65 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 80.71 Mn |
| Sep 30, 2023 | 625,694.00 |
| Jun 30, 2023 | 625,694.00 |